SignalXSignalX

ITGR Integer Holdings Corp

FY2025 10-K
Filed: Feb 23, 2026
Health Care
Electromedical & Electrotherapeutic ApparatusSEC EDGAR
Integer Holdings Corp Overview

Integer Holdings Corp (ITGR) filed its fiscal year 2025 10-K annual report with the SEC on Feb 23, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • • Pure-play medtech CDMO focused on Cardio & Vascular, Neuromodulation, and Cardiac Rhythm Management markets
  • • Acquisitions in 2025: Biocoat, VSi Parylene, and Precision Coatings added surface coating technologies and complementary capabilities
+3 more insights

Management Discussion & Analysis

  • • Revenue $1.854B, up 8.0% YoY ($137M increase); Cardio & Vascular strongest segment $1.107B (+16.6%), Other Markets weakest $77.8M (-26.9%)
  • • Gross margin 27.0% vs 26.7% YoY, gross profit up 9.0% ($41.4M); operating expenses up $28.3M; net income down to $102.8M from $121.1M
+3 more insights

Risk Factors

  • • Regulatory risk: Compliance with EU Corporate Sustainability Reporting Directive and California climate rules may increase costs and impact profitability
  • • Geopolitical risk: Supply chain exposed to wars in Ukraine and Middle East, U.S.-China tensions, tariffs on steel and copper impacting import costs
+3 more insights

Financial Summary
XBRL

Revenue

$1.9B

Net Income

$103M

Gross Margin

27.0%

Operating Margin

11.9%

Net Margin

5.5%

ROE

5.9%

Total Assets

$3.4B

EPS (Diluted)

$2.89

Operating Cash Flow

$196M

Source: XBRL data from Integer Holdings Corp FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Integer Holdings Corp

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available